Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A study of blood coagulation parameters

R L Newman, M Sirridge, M Brinkman

    American Journal of Obstetrics and Gynecology
    |May 1, 1976
    PubMed
    Summary

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Physicochemical and functional assessment of messenger RNA 5'Cap-end impurities under forced degradation conditions.

    Molecular therapy. Nucleic acids·2025
    Same author

    [An older patient with depression, anxiety and acute amnesia].

    Tijdschrift voor psychiatrie·2023
    Same author

    Developing and testing a case-management intervention to support the return to work of health care workers with common mental health disorders.

    Journal of public health (Oxford, England)·2022
    Same author

    Correction to: The association between sarcopenia and quality of life in patients undergoing colorectal cancer surgery: an exploratory study.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2021
    Same author

    Strangulating Intestinal Obstruction: A Review of 115 Cases.

    The Australian and New Zealand journal of surgery·2017
    Same author

    Urinary tract infection after voiding cystourethrogram.

    Journal of pediatric urology·2017

    Women on contraceptive medication showed potential changes in antithrombin III, a blood coagulation parameter. Further research is needed to confirm if these changes in antithrombin III levels impact clotting risk.

    Area of Science:

    • Reproductive health
    • Hematology
    • Pharmacology

    Background:

    • Oral contraceptive use is widespread among women of reproductive age.
    • Blood coagulation is a complex process involving multiple factors.
    • Previous studies have explored the link between hormonal contraceptives and thrombotic events.

    Purpose of the Study:

    • To investigate abnormalities in blood coagulation parameters among women using contraceptive medication.
    • To compare coagulation profiles of women on contraceptives with a control group.
    • To identify specific coagulation factors affected by contraceptive use.

    Main Methods:

    • Prospective, double-blind study design.
    • Inclusion of a control group for comparison.
    • Enrollment of 211 women over a 29-month period.
    Keywords:
    BiologyBlood Coagulation EffectsConferences And CongressesContraceptionContraceptive Agents, Estrogen--side effectsContraceptive Agents, Female--side effectsContraceptive Agents, Progestin--side effectsContraceptive Agents--side effectsDouble-blind StudiesEthynodiol Diacetate--side effectsFamily PlanningHematological EffectsHemic SystemLipid Metabolic EffectsMestranol--side effectsOral ContraceptivesOral Contraceptives, CombinedPhysiologyProspective StudiesResearch MethodologyStudies

    Related Experiment Videos

  • Analysis of various blood coagulation parameters.

    • Main Results:

    • A developing pattern was observed in antithrombin III determinations.
    • No corresponding patterns were identified in other blood coagulation parameters.
    • The clinical significance of observed antithrombin III changes remains to be determined.

    Conclusions:

    • Contraceptive medication may influence antithrombin III levels.
    • Further investigation is warranted to establish a causal link between altered antithrombin III and clotting.
    • Current evidence does not indicate widespread coagulation abnormalities in women on contraceptives.